To study the role of IGF1R signaling in breast cancer, we recently evaluated the tumor promoting capacity of chronic insulin analogue treatment in a human relevant breast cancer (p53R270H/+WAPCre) mouse model [7]. This evidence concerns the gene IGF1R and neoplasm.